TY - JOUR
T1 - An Iron(IV)-Oxo Intermediate Initiating l -Arginine Oxidation but Not Ethylene Production by the 2-Oxoglutarate-Dependent Oxygenase, Ethylene-Forming Enzyme
AU - Copeland, Rachelle A.
AU - Davis, Katherine M.
AU - Shoda, Tokufu Kent C.
AU - Blaesi, Elizabeth J.
AU - Boal, Amie K.
AU - Krebs, Carsten
AU - Bollinger, J. Martin
N1 - Funding Information:
This work was supported by the Office of Basic Energy Science within the Department of Energy Office of Science (BES Award DE-SC0016255). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). Data were also collected at the Advanced Light Source, a Department of Energy Office of Science User Facility under Contract DE-AC02-05CH11231. The Berkeley Center for Structural Biology is supported by the Howard Hughes Medical Institute and the National Institutes of Health, National Institute of General Medical Sciences, Grant P30 GM124169. K.M.D. is grateful for support from the National Institutes of Health, Pathway to Independence Award (4R00GM129460). We thank Dr. Benjamin Allen for technical assistance and Prof. Todd Sowers at the Pennsylvania State Earth and Environmental Systems Institute for GC-FID analysis.
Publisher Copyright:
© 2021 American Chemical Society.
PY - 2021/2/10
Y1 - 2021/2/10
N2 - Ethylene-forming enzyme (EFE) is an ambifunctional iron(II)- and 2-oxoglutarate-dependent (Fe/2OG) oxygenase. In its major (EF) reaction, it converts carbons 1, 2, and 5 of 2OG to CO2 and carbons 3 and 4 to ethylene, a four-electron oxidation drastically different from the simpler decarboxylation of 2OG to succinate mediated by all other Fe/2OG enzymes. EFE also catalyzes a minor reaction, in which the normal decarboxylation is coupled to oxidation of l-arginine (a required activator for the EF pathway), resulting in its conversion to l-glutamate semialdehyde and guanidine. Here we show that, consistent with precedent, the l-Arg-oxidation (RO) pathway proceeds via an iron(IV)-oxo (ferryl) intermediate. Use of 5,5-[2H2]-l-Arg slows decay of the ferryl complex by >16-fold, implying that RO is initiated by hydrogen-atom transfer (HAT) from C5. That this large substrate deuterium kinetic isotope effect has no impact on the EF:RO partition ratio implies that the same ferryl intermediate cannot be on the EF pathway; the pathways must diverge earlier. Consistent with this conclusion, the variant enzyme bearing the Asp191Glu ligand substitution accumulates μ4 times as much of the ferryl complex as the wild-type enzyme and exhibits a μ40-fold diminished EF:RO partition ratio. The selective detriment of this nearly conservative substitution to the EF pathway implies that it has unusually stringent stereoelectronic requirements. An active-site, like-charge guanidinium pair, which involves the l-Arg substrate/activator and is unique to EFE among four crystallographically characterized l-Arg-modifying Fe/2OG oxygenases, may serve to selectively stabilize the transition state leading to the unique EF branch.
AB - Ethylene-forming enzyme (EFE) is an ambifunctional iron(II)- and 2-oxoglutarate-dependent (Fe/2OG) oxygenase. In its major (EF) reaction, it converts carbons 1, 2, and 5 of 2OG to CO2 and carbons 3 and 4 to ethylene, a four-electron oxidation drastically different from the simpler decarboxylation of 2OG to succinate mediated by all other Fe/2OG enzymes. EFE also catalyzes a minor reaction, in which the normal decarboxylation is coupled to oxidation of l-arginine (a required activator for the EF pathway), resulting in its conversion to l-glutamate semialdehyde and guanidine. Here we show that, consistent with precedent, the l-Arg-oxidation (RO) pathway proceeds via an iron(IV)-oxo (ferryl) intermediate. Use of 5,5-[2H2]-l-Arg slows decay of the ferryl complex by >16-fold, implying that RO is initiated by hydrogen-atom transfer (HAT) from C5. That this large substrate deuterium kinetic isotope effect has no impact on the EF:RO partition ratio implies that the same ferryl intermediate cannot be on the EF pathway; the pathways must diverge earlier. Consistent with this conclusion, the variant enzyme bearing the Asp191Glu ligand substitution accumulates μ4 times as much of the ferryl complex as the wild-type enzyme and exhibits a μ40-fold diminished EF:RO partition ratio. The selective detriment of this nearly conservative substitution to the EF pathway implies that it has unusually stringent stereoelectronic requirements. An active-site, like-charge guanidinium pair, which involves the l-Arg substrate/activator and is unique to EFE among four crystallographically characterized l-Arg-modifying Fe/2OG oxygenases, may serve to selectively stabilize the transition state leading to the unique EF branch.
UR - http://www.scopus.com/inward/record.url?scp=85100680381&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100680381&partnerID=8YFLogxK
U2 - 10.1021/jacs.0c10923
DO - 10.1021/jacs.0c10923
M3 - Article
C2 - 33522811
AN - SCOPUS:85100680381
SN - 0002-7863
VL - 143
SP - 2293
EP - 2303
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 5
ER -